Table 4 Multiple linear regression analyses of determinants of bone mineral density (BMD) in patients with type 1 and type 2 diabetes
From: Prevalence and determinants of osteoporosis in patients with type 1 and type 2 diabetes mellitus
| Â | Diabetes mellitus type 1 | |||
|---|---|---|---|---|
| Â | Dependent variable: lumbar BMD | Dependent variable: femoral neck BMD | ||
| Â | Parameter estimate; SE | p-value | Parameter estimate; SE | p-value |
Gender (women vs. men) | 0.0050; 0.02 | 0.84 | −0.019; 0.02 | 0.32 |
Age | −0.0025; 0.001 | 0.04 | −0.003; 0.0009 | 0.0004 |
Duration of diabetes | −0.0009; 0.001 | 0.51 | −0.0009; 0.001 | 0.51 |
BMI | 0.013; 0.004 | 0.001 | 0.011; 0.003 | 0.0003 |
Presence of micro- or macrovascular complications | 0.004; 0.03 | 0.88 | 0.022; 0.02 | 0.38 |
HbA1c | −0.02; 0.01 | 0.08 | −0.008; 0.008 | 0.37 |
| Â | Diabetes mellitus type 2 | |||
| Â | Dependent variable: lumbar BMD | Dependent variable: femoral neck BMD | ||
| Â | Parameter estimate; SE | p-value | Parameter estimate; SE | p-value |
Gender (women vs. men) | −0.05; 0.02 | 0.02 | −0.079; 0.02 | 0.0001 |
Age | −0.003; 0.001 | 0.02 | −0.003; 0.001 | 0.001 |
Duration of diabetes | 0.004; 0.001 | 0.01 | 0.00047; 0.001 | 0.704 |
BMI | 0.007; 0.002 | 0.002 | 0.010; 0.002 | 0.0001 |
Presence of micro- or macrovascular complications | −0.0006; 0.03 | 0.98 | −0.016; 0.02 | 0.51 |
HbA1c | −0.0126; 0.008 | 0.15 | −0.01; 0.007 | 0.14 |